Organon & Co. (OGN) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Organon & Co..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:04.800 question during this time, please press star 1 on your telephone keypad. 00:00:04.800 -- 00:00:09.100 I would now like to turn the conference over to Jennifer Halchuk, Vice President Investor 00:00:09.100 -- 00:00:12.280 Relations. You may begin. 00:00:12.640 -- 00:00:14.880 Thank you, operator, and good morning, everyone. 00:00:14.880 -- 00:00:18.000 Thank you for joining Organon's second quarter earnings call. 00:00:18.000 -- 00:00:23.160 With me today are Kevin Ali, Organon's Chief Executive Officer, and Matt Walsh, our 00:00:23.160 -- 00:00:26.940 Chief Financial Officer. Juan Camilo Arjona-Ferreira, 00:00:26.940 -- 00:00:32.160 Organon's Head of R&D, will also be joining for the Q&A portion of this call. 00:00:32.160 -- 00:00:36.620 Today we will be referencing a presentation that will be visible during this call for 00:00:36.620 -- 00:00:41.000 those of you on our webcast. This presentation will also be available following this 00:00:41.000 -- 00:00:45.960 call on the events and presentation section of our Organon Investor Relations website 00:00:45.960 -- 00:00:48.580 at .organon.com. 00:00:49.600 -- 00:00:53.600 Before we begin, I would like to caution listeners that certain information discussed 00:00:53.600 -- 00:00:58.320 by management during this conference call will include forward-looking statements. 00:00:58.320 -- 00:01:02.400 Actual results could differ materially from those stated or implied by forward-looking 00:01:02.400 -- 00:01:07.100 statements due to risks and uncertainties associated with the company's business, which 00:01:07.100 -- 00:01:11.380 are discussed in the company's filings with the Securities and Exchange Commission, including 00:01:11.380 -- 00:01:15.200 their 10K and subsequent periodic filing...